Willow Biosciences (TSX:WLLW) Other Income (Expense) : C$0.13 Mil (TTM As of Dec. 2024)

View and export this data going back to 1983. Start your Free Trial

What is Willow Biosciences Other Income (Expense)?

Willow Biosciences's other income expense for the Willow Biosciences's pretax income for the three months ended in Dec. 2024 was C$0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.13 Mil.

Willow Biosciences Other Income (Expense) Historical Data

The historical data trend for Willow Biosciences's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Other Income (Expense) Chart

Willow Biosciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

-17.22

16.65

3.37

0.32

0.13

Willow Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Income (Expense)	Get a 7-Day Free Trial															0.31	0.13	-	-	-

Willow Biosciences Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.13 Mil.

Willow Biosciences (TSX:WLLW) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Willow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (TSX:WLLW) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

CANSF:USA 45CN:Germany

Address

202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6

Website

https://www.willowbio.com

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.

Executives

Christopher Kenneth Savile	Director, Senior Officer
Travis Doupe	Senior Officer
Patricia Ranija Choudhary	Director
Sadiq Lalani	Director
Barbara Elaine Munroe	Director
Peter Seufer-wasserthal	Director
Trevor Anthony Peters	Director, Senior Officer
Troy Tapan Talkkari	Senior Officer

Willow Biosciences Headlines

No Headlines